← Eichor
Study identifier: NCT06822881 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

CT1190B in the Treatment of Patients With Moderate to Severe Refractory Systemic Lupus Erythematosus (SLE) or Refractory/Progressive Systemic Sclerosis (SSc)

Condition: Systemic Lupus Erythematosus (SLE) · Systemic Sclerosis (SSc)  ·  Sponsor: Beijing GoBroad Hospital

PhasePhase 1
Planned participants27
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

A Clinical Study Exploring CT1190B in the treatment of patients with moderate to severe refractory systemic lupus erythematosus (SLE) or refractory/progressive systemic sclerosis (SSc)

This description comes directly from the study's public registry record.

Talk to the study team

Jing Pan  ·  010-50847588  ·  panj@gobroaddhealthcare.com

Always discuss trial participation with your own doctor first.

Locations (1)

Beijing GoBroad HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06822881